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In the European Union (EU) 72,334 tuberculosis (TB) 
cases were notified in 2011, of which 16,116 (22%) had 
extrapulmonary tuberculosis (EPTB). The percentage 
of TB cases with EPTB ranged from 4% to 48% in the 
reporting countries. This difference might be explained 
by differences in risk factors for EPTB or challenges in 
diagnosis. To assess the practices in diagnosis of EPTB 
we asked European Union/European Economic Area 
(EU/EEA) countries to participate in a report describ-
ing the diagnostic procedures and challenges in diag-
nosing EPTB. Eleven EU Member States participated 
and reports showed that in the majority EPTB is diag-
nosed by a pulmonologist, sometimes in collaboration 
with the doctor who is specialised in the organ where 
the symptoms presented. In most countries a medi-
cal history and examination is followed by invasive 
procedures, puncture or biopsy, to collect material 
for confirmation of the disease (by culture/histology/
cytology). Some countries also use the tuberculin skin 
test or an interferon-gamma-release-assay. A wide 
variety of radiological tests may be used. Countries 
that reported challenges in the diagnosis of EPTB 
reported that EPTB is often not considered because it 
is a rare disease and most medical professionals will 
not have experience in diagnosing EPTB. The fact that 
EPTB can present with a variety of symptoms that may 
mimic symptoms of other pathologies does pose a fur-
ther challenge in diagnosis. In addition, obtaining an 
appropriate sample for confirmation of EPTB was fre-
quently mentioned as a challenge. In summary, diag-
nosis of EPTB poses challenges due to the diversity of 
symptoms with which EPTB may present, the low level 
of suspicion of clinicians, and due to the difficulty in 
obtaining an adequate sample for confirmation.
Introduction
Tuberculosis (TB) is an airborne infectious disease 
caused by Mycobacterium tuberculosis. It most com-
monly affects the lungs, but it can affect virtually any 
organ. A case with TB in any site other than pulmonary 
is considered an extrapulmonary TB (EPTB) case. In 
2011, globally 6.2 million TB cases were notified and 
0.8 million cases with EPTB [1]. The most common site 
of EPTB is lymph nodes [2]. Other sites include pleura, 
urogenital tract, bones and joints, meninges, cen-
tral nervous system (CNS), bowel and/or peritoneum, 
pericardium, and skin. Some types of EPTB, e.g. tuber-
culosis meningitis, cause substantial mortality and 
morbidity in children and adults [3]. 
Studies from the Netherlands and United States 
showed that EPTB is more often diagnosed in women 
and is associated with ethnic minorities and those born 
in other countries [2,4-6]. Also, studies from different 
geographical areas have shown that human immu-
nodeficiency virus (HIV)-infected individuals have a 
higher frequency of EPTB [2,5-7]. In general, EPTB 
affects people with a weak immune system caused by 
diabetes, HIV, or malnourishment, very young children 
and elderly, or those undergoing prolonged treatment 
with chemotherapy or cortisone [5].
Since EPTB can affect virtually all organs, it has a wide 
variety of clinical manifestations, which may cause dif-
ficulty and delay in diagnosis. This is illustrated by the 
many published case reports [8,9]. It is also illustrated 
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by the longer health system delays in diagnosis of 
EPTB compared to pulmonary TB [10-12]. 
In the European Union (EU) 16,116 EPTB cases were noti-
fied in 2011, i.e. 22% of all TB cases [13]. The percent-
age of TB cases with EPTB differed widely from 4% of 
all notified TB cases in Hungary up to 48% in the United 
Kingdom (UK). This difference might be explained by 
differences in risk factors for EPTB. However, it could 
also result from challenges in diagnosis. In this study 
we assessed the challenges in diagnosing EPTB in EU/
European Economic Area (EEA) countries.
Methods
We approached the officially nominated EU/EEA 
national TB surveillance contacts points for the 
European Centre for Prevention and Control (ECDC) 
in Stockholm, Sweden, by email in August 2012 and 
asked whether they were interested in participating in 
a study on diagnosing EPTB. Those who indicated inter-
est were requested to provide a description of practices 
leading to EPTB diagnosis in their country. They were 
specifically asked to answer the following questions: 
(i) what are the procedures for diagnosing EPTB in your 
country?; (ii) who is in charge of diagnosing and treat-
ing EPTB in your country?; and (iii) what are specific 
challenges in the diagnosis of EPTB in your country? In 
addition, we asked whether the country had guidelines 
available for diagnosis of EPTB.
Contact points were asked to submit a report by 1 
October 2012. The reports were reviewed and edited 
and the edited versions were shared between the par-
ticipating countries, which were particularly asked to 
answer follow-up questions and provide corrections 
and additional clarifications to their own report. 
In addition to the country reports we retrieved data 
on pulmonary and EPTB from the ‘Tuberculosis sur-
veillance and monitoring in Europe, 2013 (situation in 
2011) report’, for the 11 countries that participated in 
the study [14].
Country reports
The countries that participated in the study consisted 
of 11 EU Member States. In Table 1 and 2, we provide 
the main epidemiological information about pulmonary 
and EPTB in the 11 countries. All countries provided a 
description of the procedures to diagnose EPTB. Nine 
Member States additionally referred to guidelines 
available in their country for EPTB diagnosis (Table 3). 
Below we provide the country descriptions in alpha-
betical order. For all countries, the initial diagnosis 
relied on a medical examination, but in this study more 
Table 1




TB cases with 
extrapulmonary TB
Extrapulmonary TB %
N Notification rate per 100,000 population N
Notification rate per 
100,000 population
Austriaa 687 8.2 136 1.6 20
Czech Republic 600 5.7 78 0.7 13
Germanya 4,316 5.3 926 1.1 21
Malta 33 7.9 11 2.6 33
Netherlands 1,007 6.0 441 2.6 44
Poland 8,478 22.2 599 1.6 7
Romania 19,212 89.7 2,781 13.0 14
Slovakia 399 7.3 62 1.1 16
Slovenia 192 9.4 27 1.3 14
Sweden 586 6.2 228 2.4 39
United Kingdoma 8,963 14.3 4,313 6.9 48
TB: tuberculosis.





Major sites of extrapulmonary tuberculosis in 11 European Union Member States, 2011
Country
























Austria 65 (48) 20 (15) 16 (12) 8 (6) 3 (2) 8 (6) 1 (1) 2 (1) 2 (1) 11 (8)
Czech Republic 34 (44) 16 (21) 6 (8) 2 (3) 6 (8) 0 (0) 0(0) 0(0) 2 (3) 12 (15)
Germany 431 (47) 147 (16) 90 (10) 67 (7) 34 (4) 43 (5) 22 (2) 13 (1) 9 (1) 70 (8)
Malta 6 (55) 1 (9) 1 (9) 0 (0) 1 (9) 0 (0) 1 (9) 0 (0) 0 (0) 1 (9)
Netherlands 225 (51) 64 (15) 19 (4) 11 (2) 26 (6) 33 (7) 3 (1) 0 (0) 7 (2) 53 (12)
Poland 149 (25) 214 (36) 68 (11) 40 (7) 35 (6) 12 (2) 10 (2) 16 (3) 2 (0) 53 (9)
Romania 535 (19) 1,606 (58) 117 (4) 89 (3) 129 (5) 65 (2) 129 (5) 0 (0) 3 (0) 108 (4)
Slovakia 20 (32) 18 (29) 7 (11) 0 (0) 13 (21) 1 (2) 0 (0) 0 (0) 0 (0) 3 (5)
Slovenia 10 (37) 11 (41) 1 (4) 1 (4) 1 (4) 3 (11) 0 (0) 0 (0) 0 (0) 0 (0)
Sweden 139 (61) 15 (7) 2 (1) 11 (5) 19 (8) 20 (9) 5 (2) 0 (0) 3 (1) 14 (6)
United Kingdoma 2,360 (49) 492 (10) 130 (3) 181 (4) 320 (7) 349 (7) 150 (3) 89 (2) 61 (1) 647 (14)
CNS: central nervous system.
a  United Kingdom data were provided by the Health Protection Agency and data were provided for all sites of extrapulmonary tuberculosis for 
a case. The 4,313 extrapulmonary tuberculosis cases had 4,779 sites of disease.
Source: [14].
Table 3
Availability of guidelines for the diagnosis of extrapulmonary tuberculosis in 11 European Union Member States, 2012
Country Guidelines for diagnosis of  extrapulmonary TB available (yes/no) If guidelines available, name of document References
Austria No NA NA
Czech Republic Yes TBC dospělých. Standard léčebného plánu; Standard léčebného plánu - tuberkulóza dětí a mladistvých [23,24]
Germany Yesa 
Empfehlungen zur Therapie, Chemoprävention und 
Chemoprophylaxe der Tuberkulose im Erwachsenen- und 
Kindesalter
[25]
Malta Yes Prevention, Control and Management of Tuberculosis - A National Strategy for Malta [26]
Netherlands Yesb Handboek TBC-bestrijding Nederland;NVMM-richtlijn Mycobacteriële laboratoriumdiagnostiek [21,27]
Poland Yes Podręcznik gruźlicy-zalecenia NPZG [17]
Slovakia Yes
Professional guidance of the Ministry of Health for the 
management of tuberculosis and other mycobacteriosis and for 
screening and follow up in the field of phthisiology
[28]
Slovenia Yes National Tuberculosis Programme Slovenia – Clinical diagnosis and treatment of TB [29]
Sweden Yes Tuberkulos – Vägledning för sjukvårdspersonal [30]
Romania Noc NA NA
United Kingdom Yes Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control [20]
NA: not applicable; TB: tuberculosis.
a Guidelines for diagnosis of extrapulmonary TB are partially available.
b The guidelines for diagnosis of extrapulmonary TB are focused on laboratory diagnostics.
c Although some recommendations are included in the norms for the implementation of the Romanian TB programme.
4 www.eurosurveillance.org
emphasis is given to the tests to confirm the clinical 
diagnosis.
Austria
Between 2008 and 2011, 120 to 140 cases of EPTB were 
diagnosed, which accounted for 16% to 20% of all TB 
patients. The TB incidence was about 8/100,000 popu-
lation. The most common forms of EPTB were lymphatic 
TB (65 cases, 48% of all EPTB), pleural TB (20 cases, 
15% of all EPTB), and urogenital TB (16 cases, 12% of 
all EPTB) (Table 2).
The majority of the EPTB patients are diagnosed at pul-
monary in-patient clinics. When patients are diagnosed 
outside of pulmonary clinics, e.g. internal medicine 
wards, infection control and hygienic representatives 
are usually involved. Patients diagnosed outside pul-
monary clinics are normally referred to a pulmonary 
clinic for initiation of TB treatment. The continuation-
phase of the treatment is under observation and is 
organised between out-patient pulmonary physicians 
and public health services. In paediatric cases, treat-
ment is initiated and managed in paediatric units.
One of the main challenges is the fact that EPTB is 
often not considered as a potential differential diag-
nosis. Due to the fact that there is no suspicion of 
TB, diagnostic specimens, such as biopsies or surgi-
cal specimens, are fixed and immersed in formalin or 
other preserving agents and are therefore not suitable 
for microbiological culture testing. Those specimens 
can still be used for polymerase chain reaction (PCR) 
analysis.
In Austria, anecdotal evidence suggests that TB treat-
ment is often initiated late in EPTB patients. Collection 
of data on the duration of diagnostic delay and correct 
diagnosis of TB might be useful to confirm this and if 
the case to sensitise physicians.
Czech Republic
In 2011, there were 600 cases of TB reported to the 
TB register of the Czech Republic (notification rate 
5.7/100,000 population) of which 78 (13%) cases were 
diagnosed with EPTB (Table 1). 
The procedures used in the Czech Republic to diag-
nose EPTB are radiology, microbiology, histology and 
clinical evaluation. Of the 78 cases with EPTB, 31 (40%) 
were bacteriologically confirmed. 
The most common forms of EPTB were lymphatic TB 
(34 cases, 44% of all EPTB cases), pleural TB (16 cases, 
21% of all EPTB cases), spinal TB (6 cases, 8% of all 
EPTB cases), and urogenital TB (6 cases, 8% of all EPTB 
cases) (Table 2).
Diagnosis of EPTB is normally performed by pulmonol-
ogists/phthisiologists in cooperation with the relevant 
specialist. EPTB is a rare diagnosis and therefore it is 
often not taken into consideration. Treatment is con-
ducted by pulmonologists/phthisiologists.
Germany
In 2011, 926 EPTB cases accounted for 21% of all noti-
fied TB cases in Germany (Table 1). The proportion 
of EPTB has remained stable since 2001, when EPTB 
accounted for 20% of all TB. The most common forms 
of EPTB were lymphatic TB (431 cases, 47% of all EPTB 
cases), pleural TB (147 cases, 16% of all EPTB cases) 
and urogenital TB (90 cases, 10% of all EPTB cases) 
(Table 2). The majority of EPTB patients in Germany 
were foreign born (57% in 2011).
The most common procedure for diagnosing extratho-
racic lymph nodes is direct puncture of the node or 
extirpation. Intrathoracic lymph nodes are punctured 
by endobronchial ultrasound or surgically by medi-
astinoscopy. For pleural disease, surgical or medical 
thoracoscopy and/or needle biopsy are the most com-
mon procedures. All procedures include direct micros-
copy and culture of the pleural fluid. Urogenital TB is 
diagnosed either in urine or the affected organ itself. 
Direct staining of the liquor and culture of the liquor 
are the most common confirmative diagnostic methods 
for CNS TB, but computed tomography (CT) and mag-
netic resonance imaging (MRI) together with the clini-
cal evaluation remain tools for diagnosis. 
Culture confirmation was positive in 59% of reported 
EPTB cases, the lowest culture confirmation rate was 
for CNS TB.
EPTB, especially TB of the lymph nodes, is treated by 
pulmonary or infectious diseases specialists. CNS and 
urogenital TB is usually also treated by neurologists 
and urologists.
Malta
Between 2001 and 2011, a total of 94 cases of EPTB 
were reported and the notification rates increased from 
0.26/100,000 to 2.6/100,000 (P <0.001). The propor-
tion of EPTB increased from 6% (1/16) to 33% (11/33) 
(P=0.04). In 2011, the most common forms of EPTB 
were lymphatic TB (6 cases, 54% of all EPTB cases) 
(Table 2). Sixty-two percent (58/94) of EPTB cases over 
the whole 2001 to 2011 period were among undocu-
mented African migrants. The notification rate of EPTB 
in undocumented African migrants was 106/100,000 
compared to 0.54/100,000 in people born in Malta (chi-
squared test, P=0.001). 
Diagnosis includes a medical history and examina-
tion, a tuberculin skin test (TST) and an interferon-
gamma-release-assay (IGRA) test. A chest X-ray is also 
done to exclude or confirm co-existing pulmonary TB. 
Other radiological tests may be indicated. Appropriate 
specimens are sent for histology and microbiology. 
Microbiological specimens are tested for acid-fast 
bacilli (AFB) and then cultured for Mycobacterium tuber-
culosis complex, including those that are AFB negative.
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According to national TB guidelines, all patients sus-
pected of EPTB are referred to infectious disease/TB 
specialists at the main hospital who are responsible for 
the diagnosis and treatment. However, since EPTB may 
occur in any organ, diagnosis may be initiated by the 
relevant specialist of the affected site. Between 2006 
and 2011, 84% (61/73) of the EPTB cases had speci-
mens sent for culture. Treatment is started without 
waiting for culture results if the test for acid-fast bacilli 
(direct Ziehl-Neelsen test) and the clinical picture are 
consistent with a diagnosis of TB. Treatment is contin-
ued even if subsequent culture results are negative. 
A particular challenge regarding EPTB in Malta is detec-
tion of these cases in undocumented African migrants. 
EPTB (except thoracic EPTB) is detected by passive 
surveillance. National studies have noted that passive 
surveillance may not be very effective in detecting TB 
cases in migrants [15]. Even though migrants have free 
access to TB healthcare in Malta, they may have dif-
ficulties in approaching the healthcare system due to 
lack of information, language or cultural barriers [16]. 
This may cause diagnostic delays.
Netherlands
In 2011, 441 (44%) of the 1,007 notified TB cases in the 
Netherlands were diagnosed with EPTB (Table 1). The 
most common forms of EPTB were lymphatic TB (225 
cases, 51% of all EPTB cases), pleural TB (64 cases, 
51% of all EPTB cases) and urogenital TB (19 cases, 4% 
of all EPTB cases) (Table 2). The majority of TB patients 
in the Netherlands were foreign born (710 foreign born 
cases, 71 of all cases) and the percentage of EPTB 
cases was highest in this group. 
EPTB is diagnosed based on clinical symptoms, a 
matching medical history, risk factors indicating likeli-
hood of infection with M. tuberculosis, such as expo-
sure to an infectious TB patient and origin from or 
travel to an high endemic area, as well as results of 
histological or bacteriological tests of body material. 
TST and IGRA are not recommended for the diagnosis 
of EPTB. However, in some cases they may provide sup-
portive evidence.  
The majority of patients with symptomatic EPTB were 
diagnosed by lung physicians (194 cases, 44% of all 
EPTB cases) and other clinical specialists (185 cases, 
42% of all EPTB cases). In most cases, when TB is sus-
pected or diagnosed in a clinical setting, a lung physi-
cian takes charge of further diagnosis and treatment. 
Ten to 15% of the patients with EPTB were diagnosed 
by Municipal Health Services through screening of risk 
groups and contact investigation. 
Since the absolute number of patients diagnosed with 
EPTB is low, most medical professionals will only rarely 
be involved in diagnosis and treatment of EPTB. It is 
therefore a challenge to maintain sufficient knowledge 
among clinicians to avoid diagnostic delays. 
Another challenge is the confirmation of the diagnosis 
of EPTB because it can be difficult to obtain a sample 
and to confirm the diagnosis with a positive culture. In 
the group detected through active case finding in 2011, 
17% (8/47) of the cases were confirmed by culture and 
2.1% (1/47) through PCR or histology. Over the years in 
the period from 2005 to 2011, 64% (1,698/2,659) of the 
EPTB cases found through passive case finding were 
confirmed by culture and an additional 10% (262/2,659) 
were confirmed by PCR or histology. 
Poland
In 2011, 599 EPTB cases without coexisting pulmonary 
TB were notified, 7% of all TB cases (notification rate 
1.6/100.000) (Table 1). For several years the percentage 
of EPTB has been low. The reason may be insufficient 
awareness, difficulties in diagnosis or low prevalence 
of factors which are considered risk factors for EPTB. 
The most common forms of EPTB were pleural TB (214 
cases, 36% of all EPTB cases), lymphatic TB (149 cases, 
25% of all EPTB cases), and urogenital TB (68 cases, 
11% of all EPTB cases). 
Guidelines for the diagnosis of EPTB in Poland are 
included in the TB manual that was issued in 2001 
(Table 3) [17]. Diagnosis is done either by pulmonolo-
gists or by others specialists, depending on the site of 
EPTB. The most common situation is that doctors are 
supported by pulmonologists in the diagnosis of EPTB. 
Pulmonologists are responsible for the treatment of 
EPTB cases. If hospitalisation is required, patients are 
usually treated in TB wards, under the responsibility of 
pulmonologists. Cases of TB/HIV co-infection are most 
often diagnosed by infectious diseases specialists and 
often also treatment is provided by infectious diseases 
specialists. 
The doctor performing the diagnosis decides whether 
and which invasive procedures are used for obtain-
ing clinical material for microbiological diagnosis. 
Pulmonologists believe that TB is too often diagnosed 
without microbiological confirmation (only 35% of the 
EPTB cases were bacteriologically confirmed between 
2007 and 2011) and for this reason there may be sub-
stantial over-diagnosis. For example, pleural TB was 
bacteriologically confirmed in 56% of the cases in 2011; 
pericardial TB was confirmed in 50% of the reported 
cases; and intrathoracic lymphatic TB in children was 
confirmed in only 13% of the cases. 
In Poland, data on delay in diagnosis of EPTB are not 
collected. However, pulmonologists consider based on 
anecdotal evidence that other specialists are not aware 
of TB. 
Romania
In 2011, 2,781 EPTB cases were notified, accounting for 
14% of all TB cases (Table 1). The proportion of EPTB 
increased from 11% in 2002 to 14% in 2011. The most 
common forms of EPTB were pleural TB (1,606 cases, 
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58% of all EPTB cases), lymphatic TB (535 cases, 19% 
of all EPTB cases), and spinal TB and TB meningitis 
(both 129 cases, 5% of all EPTB cases). Between 8% 
and 10% of the EPTB cases were bacteriologically con-
firmed by smear and culture according to the national 
electronic TB data base. 
Diagnosis of EPTB is done by organ specific specialists 
together with the pulmonologist, while treatment of 
EPTB cases is managed by pulmonologists. 
Often patients with EPTB will need several diagnostic 
procedures by different medical units to establish the 
diagnosis. For example, lymph node TB will be investi-
gated by the pulmonologist, who will also assess epi-
demiological links with known TB patients, and might 
perform a TST and/or IGRA, chest X-ray, bronchoscopy, 
smear and culture, and histopathological examina-
tion of the specimen obtained by puncture or biopsy. 
Furthermore, ultrasound imaging might be performed 
at the Excellence Centre for Endoscopy. A radiologist 
might be involved to evaluate the lymph node using CT 
or MRI. Finally a surgeon might do a biopsy or remove 
the lymph node. 
The involvement of different persons in the diagnosis 
may cause diagnostic delays.
Slovakia
In Slovakia, 399 TB cases were notified in 2011 
(7.3/100,000 population). Of those 62 (16%) were diag-
nosed with EPTB. The most common forms of EPTB 
were lymphatic TB (20 cases, 32% of all EPTB cases), 
pleural TB (18 cases, 29% of all EPTB cases), and spinal 
TB (13 cases, 21% of all EPTB cases). 
The standard procedure for diagnosing EPTB is punc-
ture or biopsy for culture and histology or/and cytology. 
Eighteen percent of the EPTB cases were bacteriologi-
cally confirmed. Histological and cytological confir-
mation was obtained in 28%.EPTB is also diagnosed 
based on clinical symptoms, medical history, risk fac-
tors, such as close contact with TB patients, presence 
of TB in the family, patients who have immigrated from 
high incidence settings, and results of histological or 
bacteriological tests of body material. TST and IGRA 
tests are also used. Diagnostic tests are performed 
after a specialist refers the suspected EPTB case to the 
National Institute for TB, Lung Diseases and Thoracic 
Surgery for further investigation. In 2011, in 33 (54%) 
EPTB cases the decision of the clinician to start TB 
treatment was based on clinical symptoms, history and 
non-specific examinations’ results.
Thirty-seven (60%) patients with symptomatic EPTB 
were diagnosed by pulmonologists and other clinical 
specialists. In most cases, when TB is suspected or 
diagnosed, a lung physician is involved and is respon-
sible for further diagnosis and treatment. If hospitali-
sation is required, usually patients are treated in the 
specialised EPTB wards of the National TB Institute, 
under the care of a pulmonologist in collaboration with 
other specialists.
The main challenge is to maintain sufficient knowledge 
on TB among clinicians to avoid long diagnostic delays 
in those with symptomatic EPTB. EPTB is too often 
diagnosed empirically without microbiological confir-
mation and for this reason often over-diagnosed. 
Slovenia
In 2011, 192 cases of TB were notified in Slovenia, 133 
(69%) with pulmonary TB, 27 (14%) with EPTB and 32 
patients (17%) with pulmonary TB and EPTB. The most 
common forms of EPTB were pleural TB (11 cases, 41% 
of all EPTB cases) lymphatic TB (10 cases, 37% of all 
EPTB cases) and gastrointestinal TB (3 cases, 11% of all 
EPTB cases). In 23 (85% of all EPTB cases) cases, diag-
nosis was based on typical histological images, and 
confirmed by culture from biopsy material. In four (15% 
of all EPTB cases) patients, the disease was not culture 
confirmed. EPTB was diagnosed post mortem based on 
histology in three patients. In the past five years the 
proportion of patients with EPTB varied between 14 
and 18%.
According to the recommendations of the National TB 
programme and the guidelines for diagnosis and treat-
ment of TB, all patients suspected of EPTB should be 
confirmed by culture before starting treatment. Often 
pulmonologist cooperate with specialists from other 
specialties, such as orthopaedic surgeons, thoracic 
surgeons, urologists and others to diagnose EPTB.
Pulmonologists are responsible for the treatment of 
both pulmonary TB and EPTB. Pulmonary TB should be 
excluded using relevant samples in patients suspected 
or diagnosed with EPTB. 
Sweden
In 2011, 586 TB cases were notified in Sweden of which 
228 (39%) had EPTB. During the last five years (2007 to 
2011) the percentage of EPTB of all TB cases reported 
has been quite stable with an average of 40%. The 
high percentage of EPTB might be due to good cover-
age of reporting. The most common forms of EPTB were 
lymphatic TB (139 cases, 61% of all EPTB cases), gas-
trointestinal TB (20 cases, 9% of all EPTB cases), and 
spinal TB (19 cases, 8% of all EPTB cases). 
The standard procedure for diagnosing EPTB is puncture 
or biopsy for culture and histology/cytology. Puncture 
and/or biopsy are most frequently performed to diag-
nose lymph node TB. However, it is also performed if 
TB is suspected at other sites, including skeletal and 
gastrointestinal TB. To diagnose TB in intrathoraci-
cal lymph nodes, endobronchial puncture or biopsy 
through mediastinoscopy is considered. TB of the CNS 
(meningitis, tuberculoma) is also confirmed by culture. 
The only type of EPTB that is never confirmed by culture 
is retinal TB. The diagnosis is always on suspicion of 
an ophthalmologist who refers to a clinic of infectious 
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diseases for further investigation; i.e. chest X-ray and 
immunological tests like IGRA. Often an ex-juvantibus 
treatment will be initiated and the ophthalmologist will 
follow the clinical course. Of the EPTB cases an average 
of 70% is bacteriologically confirmed. An additional 
five to10% is diagnosed by histology showing necrotis-
ing granuloma and the remaining on clinical grounds.
Infectious disease clinics are in charge of diagnosing 
and treating all cases of EPTB (and in most regions also 
pulmonary TB), but diagnosis might happen in another 
speciality, depending on the presenting symptoms. 
Paediatricians usually care for EPTB cases in children 
<18 years of age, often in co-operation with the infec-
tious disease clinic. 
United Kingdom
In the UK the proportion of cases with TB in extra 
pulmonary sites has steadily increased over the last 
decade [18]. In 2011, 48% (4,313 EPTB cases/8,963 TB 
cases) of EPTB cases were diagnosed with exclusive 
EPTB with a further 828 cases having disease affect-
ing both pulmonary and extrapulmonary sites. In the 
UK all sites of EPTB are registered. In total 4,779 dif-
ferent sites were registered for the 4,313 EPTB cases. 
The most common forms of EPTB were lymphatic TB, 
2,390/4,779 (49%), pleural TB, 492/4,779 (10%), and 
gastrointestinal TB, 349/4,779 (7%).  
The diagnosis of patients often requires specific proce-
dures to obtain samples such as lumbar puncture and 
a brain scan (MRI or CT) in those with CNS TB. The UK 
National Institute for Health and Clinical Excellence has 
outlined recommendations for the diagnosis of EPTB 
[19,20].
As EPTB can affect several organs, its clinical pres-
entation may mimic symptoms and signs of other 
pathologies. Inevitably, patients present to the clinical 
speciality that usually treats the commonest differen-
tial diagnoses for each site of disease. For example, 
renal TB may be diagnosed by nephrologists, CNS TB 
may present to neurologists and skin TB to dermatolo-
gists. In general, patients with EPTB are managed with 
support from experts with knowledge of TB. 
Discussion
In 2011, 72,334 TB cases were notified by 29 EU/EEA 
countries. Of these 16,116 (22%) were EPTB cases [13]. 
In the EU/EEA countries, extrapulmonary TB was more 
frequent in females, in children, and in individuals 
who were foreign born or had citizenship from another 
country [13]. The percentage of TB cases with EPTB 
notified by the different EU/EEA countries ranged from 
4 to 48% (and 67% in Iceland with 6 EPTB cases). In the 
countries presented in this study the percentage EPTB 
ranged from 7% in Poland to 48% in the UK. 
Several countries have recommendations for the diag-
nosis of EPTB (Table 3). The UK recommendations spec-
ify what imaging technique should be used for each 
site, what type of biopsy should be performed and 
which material should be cultured [20]. The guidelines 
in the Netherlands are focused on laboratory diag-
nostics [21]. In most other countries a medical history 
and examination is followed by invasive procedures, 
puncture or biopsy, to collect material for confirmation 
(culture/histology/cytology/PCR) of the disease. Some 
countries (Malta, Slovakia and Romania) also use TST 
or IGRA. A wide variety of imaging tests may be used: 
ultrasound, CT or MRI. 
Not all countries reported challenges in the diagno-
sis of EPTB, but those that did, reported that EPTB is 
often not considered because it is a rare disease and 
therefore not included in the differential diagnosis. If 
TB is not considered body material will not be sent for 
bacteriological confirmation or will be processed in 
such a way that it will not be subsequently usable for 
bacteriological confirmation if EPTB is suspected at a 
later stage. In cases where TB is considered, it is often 
difficult to obtain body material to confirm the diagno-
sis. Diagnosis of EPTB might require several diagnostic 
procedures by different medical units. The involvement 
in the diagnosis of different persons/units may cause 
a delay in diagnosis. The fact that EPTB can present 
with a variety of symptoms that may mimic symptoms 
of other pathologies poses a further challenges in 
diagnosis. 
Since by definition EPTB does not affect the lung 
parenchyma, the tracheobronchial tree, EPTB patients 
will normally not present to pulmonologists. They will 
seek care from a general practitioner, a paediatrician 
or from an organ specific specialist who will infre-
quently encounter an EPTB case and do therefore not 
include EPTB in their differential diagnosis. The coun-
tries reported that in the majority of cases, EPTB is 
diagnosed by a pulmonologist, sometimes in collabo-
ration with the organ specific specialist. Alternatively, 
e.g. in Malta, patients suspected of EPTB are referred 
to infectious disease or TB specialists. Thus, patients 
with EPTB need be referred from a more generalist doc-
tor, or organ specific specialist, to a pulmonologist. 
This may increase the diagnostic delay.
Longer health system delays in diagnosis of EPTB com-
pared to pulmonary TB have been reported [10-12]. The 
countries participating in this study did not have data 
available on delays in diagnosis, but anecdotal evi-
dence suggests that delays in diagnosis of EPTB might 
be long. Systematic collection of information on diag-
nostic delay might be useful to understand the extent 
of the problem and to sensitise physicians.
In most countries, the treatment of EPTB is the respon-
sibility of the pulmonologist. In some countries, such 
as Sweden and the UK, infectious disease special-
ists are involved or responsible for treatment of EPTB 
cases. Paediatricians are involved in the treatment 
of EPTB in children. Since TB and EPTB is a rare dis-
ease in most EU/EEA countries not all clinicians have 
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experience with the treatment. To guarantee adequate 
treatment and treatment support, TB treatment should 
be provided by clinicians with ample experience in 
treating and supporting EPTB patients.
Countries reported large differences in the percentage 
of confirmed EPTB cases, from 10% in Romania to 80% 
in Sweden. Confirmation of EPTB was frequently men-
tioned as a challenge. Confirmation of EPTB is chal-
lenging for a number of reasons: the difficulty to obtain 
an adequate sample; the apportioning of the sample 
for various diagnostic tests resulting in non-uniform 
distribution of microorganisms; the pauci-bacillary 
nature of the specimens; the presence of inhibitors 
that undermine the performance of nucleic acid ampli-
fication-based techniques; and the lack of an efficient 
sample processing technique universally applicable on 
all types of extrapulmonary samples [22]. Diagnoses of 
EPTB without microbiological confirmation may result 
in over-diagnosis. 
Conclusion
Diagnosis of EPTB poses challenges due to the diver-
sity of symptoms with which EPTB may present, the 
low level of suspicion among clinicians, and the diffi-
culty in obtaining an adequate sample for confirmation. 
Raising awareness among non-pulmonary physicians 
about EPTB and guidelines for diagnosis and treat-
ment of EPTB may result in more timely and adequate 
diagnosis.
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